National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Aclidinium bromide (Eklira Genuair®)

Indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD)

Rapid Review

Commenced Completed Outcome
23/10/2012 26/10/2012 Full Pharmacoeconomic Evaluation Not Recommended